Literature DB >> 2531656

The dopamine D2 receptor: two molecular forms generated by alternative splicing.

R Dal Toso1, B Sommer, M Ewert, A Herb, D B Pritchett, A Bach, B D Shivers, P H Seeburg.   

Abstract

Cloned human dopamine D2 receptor cDNA was isolated from a pituitary cDNA library and found to encode an additional 29 amino acid residues in the predicted intracellular domain between transmembrane regions 5 and 6 relative to a previously described rat brain D2 receptor. Results from polymerase chain reactions as well as in situ hybridization revealed that mRNA encoding both receptor forms is present in pituitary and brain of both rat and man. The larger form was predominant in these tissues and, as shown in the rat, expressed by dopaminergic and dopaminoceptive neurons. Analysis of the human gene showed that the additional peptide sequence is encoded by a separate exon. Hence, the two receptor forms are generated by differential splicing possibly to permit coupling to different G proteins. Both receptors expressed in cultured mammalian cells bind [3H]spiperone with high affinity and inhibit adenylyl cyclase, as expected of the D2 receptor subtype.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531656      PMCID: PMC401577          DOI: 10.1002/j.1460-2075.1989.tb08585.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  A family of receptors coupled to guanine nucleotide regulatory proteins.

Authors:  H G Dohlman; M G Caron; R J Lefkowitz
Journal:  Biochemistry       Date:  1987-05-19       Impact factor: 3.162

2.  The interaction between D-2 dopamine receptors and GTP-binding proteins.

Authors:  K Ohara; K Haga; G Berstein; T Haga; A Ichiyama; K Ohara
Journal:  Mol Pharmacol       Date:  1988-03       Impact factor: 4.436

Review 3.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

4.  Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine.

Authors:  M O Thorner; R L Perryman; A D Rogol; B P Conway; R M Macleod; I S Login; J L Morris
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

5.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

6.  Characterization of cDNA for precursor of human luteinizing hormone releasing hormone.

Authors:  P H Seeburg; J P Adelman
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

7.  Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions.

Authors:  L C Murrin; K Gale; M J Kuhar
Journal:  Eur J Pharmacol       Date:  1979-12-07       Impact factor: 4.432

Review 8.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity.

Authors:  B K Kobilka; T S Kobilka; K Daniel; J W Regan; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

9.  In vitro deletional mutagenesis for bacterial production of the 20,000-dalton form of human pituitary growth hormone.

Authors:  J P Adelman; J S Hayflick; M Vasser; P H Seeburg
Journal:  DNA       Date:  1983

10.  Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.

Authors:  E G Peralta; A Ashkenazi; J W Winslow; D H Smith; J Ramachandran; D J Capon
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  98 in total

1.  Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding.

Authors:  Elisabetta Daré; Serguei Fetissov; Tomas Hökfelt; Håkan Hall; Sven Ove Ogren; Sandra Ceccatelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-09       Impact factor: 3.000

Review 2.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 3.  Dopamine receptor genes: new tools for molecular psychiatry.

Authors:  H B Niznik; H H Van Tol
Journal:  J Psychiatry Neurosci       Date:  1992-10       Impact factor: 6.186

4.  Alternative splicing generates metabotropic glutamate receptors inducing different patterns of calcium release in Xenopus oocytes.

Authors:  J P Pin; C Waeber; L Prezeau; J Bockaert; S F Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

5.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

Review 6.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

7.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

8.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Autoradiographic localization of dopamine D2-like receptors in the rabbit pulmonary vascular tree.

Authors:  Y Kobayashi; A Ricci; I Rossodivita; F Amenta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

10.  Modulation by chronic antipsychotic administration of PKA- and GSK3β-mediated pathways and the NMDA receptor in rat ventral midbrain.

Authors:  Bo Pan; Chao Deng
Journal:  Psychopharmacology (Berl)       Date:  2019-05-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.